A detailed history of Lmr Partners LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Lmr Partners LLP holds 14,800 shares of ABT stock, worth $1.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,800
Previous 18,800 21.28%
Holding current value
$1.74 Million
Previous $1.95 Million 13.62%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $6.02 Million - $7.37 Million
66,722 New
66,722 $7.34 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $1.08 Million - $1.28 Million
11,189 New
11,189 $1.13 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $3.43 Million - $4.17 Million
-37,481 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $2.87 Million - $3.67 Million
37,481 New
37,481 $3.43 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $1.3 Million - $1.9 Million
-20,710 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $1.63 Million - $1.81 Million
20,710 New
20,710 $1.8 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $1.72 Million - $1.87 Million
-21,037 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $3.97 Million - $4.63 Million
-54,462 Reduced 72.14%
21,037 $1.77 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $3.4 Million - $4.11 Million
51,359 Added 212.75%
75,499 $6.04 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $1.58 Million - $1.79 Million
24,140 New
24,140 $1.75 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $860,461 - $1.04 Million
-14,150 Closed
0 $0
Q2 2018

Aug 03, 2018

SELL
$57.57 - $63.54 $481,112 - $531,003
-8,357 Reduced 37.13%
14,150 $863,000
Q4 2017

Jan 30, 2018

BUY
$53.68 - $57.47 $432,875 - $463,438
8,064 Added 55.83%
22,507 $1.28 Million
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $694,130 - $774,722
14,443
14,443 $770,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.